Elsevier Launches European Journal of Cancer iPad Edition

EJC App now available on the App Store

Oxford, September 26, 2011 – Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of the iPad edition of the European Journal of Cancer (EJC). Starting with the September 2011 issue, all 18 annual issues of theEJC will be available through the EJC App on the App Store. iPad editions feature the same high quality articles that are published in the print as well as online editions. 

The EJC App includes published content from the highly popular EJC News and EJC News Focus, and offers readers the ability to customize the journal by selecting articles, tables, or figures to store and use later, as well as making notes on articles.

“We are proud that the EJC is the first European oncology journal to launch an iPad edition,” said Alexander Eggermont, Editor-in-Chief of the EJC. “It is important for our readers to have access to the journal whenever they need it. The iPad editions deliver theEJC to them in an easy to use format, straight to their device.”

The EJC App offers unprecedented portability to its readers, who can download the edition wirelessly. It is then available for reading and browsing offline, at times and in places where web access is not available. Of perhaps most significance, the journal can be read the same way on iPad as in print. The reader can flip pages forward and backward in the horizontal plane and scroll down vertically to read an individual article.

The  EJC App is available for free from the App Store.
 

# # #


About the European Journal of Cancer 
The EJC, with an Impact Factor of 4.944, is an international multidisciplinary oncology journal that publishes original research, editorial comments, review articles and news on basic and preclinical research, clinical oncology (medical, paediatric, radiation, surgical), translational oncology, and on cancer epidemiology and prevention. Led by Editor-in-Chief, Alexander Eggermont, the EJCis the official journal of the EORTC (the European Organisation for Research and Treatment of Cancer, ECCO (the European CanCer Organisation), the EACR (European Association for Cancer Research), and EUSOMA (the European Society of Breast Cancer Specialists).

About Elsevier
Elsevier is a global information analytics company that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com

Media contact
Harald Boersma
Senior Manager Corporate Relations, Elsevier
+31 20 485 27 36
h.boersma@elsevier.com